General
This is a paid press release. Contact the press release distributor directly with any inquiries.
Research and Markets
6 min read
Market opportunities in India’s Animal Pharmaceuticals Market include leveraging advanced tech like AI and IoT for innovative animal healthcare solutions, addressing rising demands due to stray animal care, and combating counterfeit medicines to enhance product efficacy and safety.
Indian Animal Pharmaceuticals Market
Dublin, Nov. 07, 2025 (GLOBE NEWSWIRE) — The “India Animal Pharmaceuticals Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The India Animal Pharmaceuticals Market was valued at USD 1.28 Billion in 2024, and is expected to reach USD 1.96 Billion by 2030, rising at a CAGR of 7.50%.
The Animal Pharmaceuticals Market refers to the sector that is responsible for the research, development, production, and marketing of drugs and healthcare products specifically tailored for veterinary medicine. This comprehensive market caters to the healthcare needs of various animals, including our beloved companions such as dogs, cats, and horses, as well as livestock such as cattle, pigs, and poultry.
In order to address the diverse health conditions and requirements of these animals, the market offers a wide range of pharmaceutical products. These include not only vaccines and antibiotics but also antiparasitic medications and medical feed additives. These products play a crucial role in promoting animal well-being, improving overall health, and enhancing productivity in livestock industries.
The Animal Pharmaceuticals Market serves a vital purpose in safeguarding public health. By preventing the spread of diseases from animals to humans, it contributes to the overall well-being and safety of both animals and humans alike. Through continuous research and innovation, this sector strives to enhance animal health, advance veterinary medicine, and ensure sustainable practices in the care and treatment of animals. With its focus on improving animal health, increasing livestock productivity, and preventing the transmission of diseases, the Animal Pharmaceuticals Market is an indispensable component of the veterinary industry.
It plays a vital role in supporting animal welfare, ensuring food safety, and maintaining the delicate balance between human and animal health. For instance, in feb 2025, Felix Pharmaceuticals is seeking to invest $200-250 million to acquire a controlling stake in a pet drug company, signaling its entry into the fast-growing animal healthcare sector. The move aligns with Felix’s strategy to diversify beyond human pharmaceuticals and tap into the rising demand for pet medicines. This potential acquisition reflects the company’s commitment to expanding its portfolio and capitalizing on opportunities in the global veterinary drug market.
Key Market Drivers